• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

4AB:GR

45.385 EUR 0.260 0.58%

As of 05:58:30 ET on 09/17/2014.

Snapshot for AbbVie Inc (4AB)

Open: 45.030 Day's Range: 45.028 - 45.885 Volume: 245
Previous Close: 45.125 52wk Range: 32.255 - 47.000 1-Yr Rtn: +33.04%

Stock Chart for 4AB

No chart data available.
  • 4AB:GR 45.385
  • 1D
  • 1M
  • 1Y
45.125
Interactive 4AB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4AB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 18.8307
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 3.1570
Est. PEG Ratio 3.1558
Market Cap (M EUR) 73,085.46
Shares Outstanding (M) 1,592.80
30 Day Average Volume 851
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.72%
Cash Dividend (USD) 0.4200
Dividend Ex-Date 07/11/2014
5 Year Dividend Growth -
Next Earnings Announcement 10/24/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4AB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 4AB

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, Hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including Multiple Sclerosis, Parkinson's, and Alzheimer's disease.

Richard A Gonzalez "Rick"Chairman/CEOWilliam J ChaseExec VP/CFO
Michael Severino "Mike"Exec VP:Research & DevelopmentLaura J SchumacherExec VP:Bus Dev/Secy /Gen Cnsl
More Company Profile & Key Executives for 4AB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil